I don't have too much to add to the coverage of yesterday's DC United game, except that i'm going to need a defibrillator by my side if Erpen is on the field again this Sunday.
OK, so the hold your camera over your head and shoot method doesn't always wind up with the proper focus. Woops! I was too lazy too get all the way up to the stage, so I didn't get any shots like this one from last year's show.
I've Hunted Man: Superchunk's cover of Night Creatures for you enjoyment on this Halloween weekend. (As always, this link doesn't seem to show up in the RSS feed for some reason. I'm too lazy to figure out why.)
Water Is On The House: This comic and this post from Comic Curmudgeon made my day.
I have exactly one month, one evening of class, one paper and one presentation left in grad school.
Red Cross - I Hate My School
Replacements - Fuck School
Update 1: Woops, links are fixed.
Update 2: Yeah, the links don't appear to work within Bloglines, but if you hop out to the actual post, they are there.
Eddie Argos of Art Brut, in the Red Room bar after their show at the Black Cat last night.
On occasion, later in the evening, the metro can give me a serious 28 Days Later vibe.
After watching DC United lose an early lead and drop a game to the New England Revolution, I'm afraid that the road to the MLS Cup is going to end with a whimper rather than a bang. Probably at the hands of Chicago again! Oh well, at least they already locked up the Supporter's Shield.
Leiomyosarcoma is a rare form of cancer, which affects about four people in every million. It spreads through the blood stream and can affect the lungs, liver, blood vessels, or any other soft tissue in the body. Presently there is no cure, only remission if it can be attained, and this rare cancer can reappear anywhere at any time. Because of its rarity, few doctors know how to treat it and it attracts very little research.
Donations to LMS research can be made to:
The National Leiomyosarcoma Foundation
129 Hawkins Road
Maryland, New York 12116
Update: The obituary ran in the Post today.